Study of PML in patients, at-risk people, and healthy volunteers
Part of Brain & nervous system, Immune system & allergy, Infections clinical trials.
This study follows people with suspected or confirmed progressive multifocal leukoencephalopathy (PML), people at higher risk, and healthy volunteers. It uses visits, brain imaging (MRI), and stored biological samples to better understand how PML progresses and who is at risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- If you have PML: it must be suspected or confirmed
- You must be able to have an MRI (no non-removable metal or incompatible implants/piercings)
- You can join all study visits and follow-up as scheduled
- You must meet the age rule: 2+ for PML patients or at-risk controls; 18+ for healthy volunteers
- You must be able to give consent (or have a legal representative who can)
- You must agree to blood/other samples and having them stored (frozen) for future testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This pilot study tests an IV medicine called brincidofovir for people with PML, a serious brain infection. The goal is to see if it can stop the virus from causing more damage.
This Phase 1 study tests a small drug (called an anti–CD8+ T cell minibody) to see how much reaches the brain. It may help researchers understand how to deliver similar treatments for multiple sclerosis, progressive multifocal leukoencephalopathy (PML), or other brain inflammation when the brain’s protective barrier is “open.”
This study follows patients with chronic viral infections affecting the brain and spinal cord. Researchers will collect spinal fluid samples and track your health over one year to better understand these infections and improve care.
This trial tests if pembrolizumab, an immunotherapy drug, can help fight a rare brain virus called PML in people whose immune systems are weakened but not due to HIV. The goal is to see if it improves recovery.
This study looks at people with multiple sclerosis who have taken Zeposia (ozanimod) and later developed a rare brain infection called PML. The goal is to understand how often this happens and to confirm cases.
This study looks at how immune-related brain or spinal cord illness shows up using exams, MRI scans, and sometimes a spinal fluid test (lumbar puncture), plus collected blood and other samples. It may help researchers better understand these conditions and improve future diagnosis or treatments.
Hear when a new Progressive Multifocal Leukoencephalopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.